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INTRODUCTION 
A classical example for hormonal control of gene expression is the induction of 
the enzymes tyrosine aminotransferase (TAT) and tryptophan oxygenase (TO).1"3 
These two enzymes are expressed exclusively in the parenchymal cells of the liver.4 
The expression of both genes is affected by glucocorticoids.5"10 In nuclear run-on assays 
it could be shown that hormonal induction involves changes in the relative rates of 
transcription of these two genes. Apart from glucocorticoid induction, the activity of 
the TAT gene is also regulated by cAMP.11-14 The accumulation of TAT mRNA after 
cAMP stimulation is a consequence of transcriptional activation of the TAT gene.15 
Combined dexamethasone and cAMP treatment leads to higher TAT mRNA con-
centrations than treatment with either inducer alone, which implies that dexameth-
asone and cAMP act by distinct mechanisms.15 
In addition to hormonal regulation, both TAT and TO genes are under devel-
opmental control. Whereas TAT enzyme activity appears around birth, TO enzyme 
activity can be detected only 2 weeks later.16 The activity of the TAT gene is affected 
by two distinct genetic loci, which appear to operate in trans on the expression of the 
TAT gene. By genetic and biochemical analysis of several albino lethal mutants of 
the mouse, a control region required for expression and inducibility of several liver 
enzymes including TAT has been assigned to the region of the albino locus on 
chromosome 7 of the mouse.17 The basal level of TAT mRNA is severely decreased, 
and the concentration of the mRNA is no longer inducible by glucocorticoids and 
cAMP, although the structural gene for TAT is still present.18 Because the mouse 
TAT structural gene is located on chromosome 8,19 the effect of this presumptive 
regulatory locus must operate in trans. 
Another locus, the so-called tissue-specific extinguisher-1 (Tse-I) has been mapped 
to chromosome 11 of the mouse.20 When chromosome 11 of a fibroblast cell is 
9 3 
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introduced by microcell fusion into a hepatoma cell expressing TAT, TAT gene activity 
is selectively extinguished, suggesting that a negatively acting factor encoded in chro-
mosome 11 is responsible for this effect. 
To study the complex control mechanism operating on these two liver-specific 
genes at the molecular level, we have isolated the TAT and TO genes from the rat 
as well as the TAT gene of the mouse.7,9,10,19 The availability of these DNA clones 
have allowed us to determine the level at which hormonal regulation of expression 
of these two genes occurs and, furthermore, allowed us to identify those sequences 
that are required for hormonal induction in eis. We demonstrate here that these sites 
represent binding sites for the glucocorticoid receptor. 
Size of Size of 
mRNA gene 
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FIGURE 1. Exon-intron structure of the rat TAT and TO genes. Open boxes represent the 
exons; connecting lines represent the intervening sequences, and are drawn to scale. The size of 
the mRNA and the size of the gene are indicated in kb pairs. 
RESULTS 
To allow analysis at the molecular level of the sequences important for the hor-
monal regulation of expression of the TO and TAT genes, we have cloned cDNA 
sequences representing these two mRNAs9,10 as well as genomic DNA containing 
these two genes.7,19 The exon-intron organization and the start site of transcription of 
these two genes was determined by electron microscopic analysis of heteroduplexes 
of mRNA with the cloned genomic DNA, as well as by SI nuclease mapping.7,10 
FIGURE 1 shows the exon-intron organization of these two genes. The coding portion 
of these genes is interrupted by multiple intervening sequences; thus the genes are 
much longer than the respective mRNAs. In order to allow studies of the molecular 
effects of the albino deletion mutations, we have isolated and characterized the mouse 
TAT gene and have shown that the rat and mouse TAT genes are very similar in 
exon-intron structure. Sequence comparison around the 5' end of the rat and mouse 
genes shows extensive homology over the entire sequence (approximately 1 kb), in-
dicating the importance of these sequences for the regulation of these two genes.19 
In order to obtain clues to possible regulatory sequences, we have analyzed the 
chromatin structure in the vicinity of the 5' end of the TO and TAT genes with regard 
to DNase I hypersensitivity. Hypersensitive sites frequently map near the 5' end of 
actively transcribed genes. Their presence has been correlated in many systems with 
the state of expression. We have found DNase I hypersensitive sites at each of the 
two promoters in liver cells of the rat22 and mouse (FIG. 2). DNase I hypersensitive 
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FIGURE 2. A glucocorticoid-inducible DNase 
I hypersensitive site far upstream of the mouse 
TAT gene. Nuclei from hormone-induced ( + 
dex) and uninduced (— dex) mouse livers were 
treated with increasing amounts of DNase I. 
After purification, the DNAs were cut with the 
restriction enzyme abutting with the probe used, 
separated on a 1% agarose gel, and blotted to 
nitrocellulose filters. The end-labeling technique 
was used for visualizing the preferential DNase 
I cleavage sites. On the right part of the figure 
these hypersensitive sites are aligned with the 5' 
flanking region of the TAT gene. 
sites of both genes are absent in kidney nuclei and therefore appear to be specific for 
the tissue expressing the genes.22 Most remarkable is the alteration in chromatin 
structure following glucocorticoid induction (FIG. 2). A strong DNase I hypersensitive 
site is detected about 2.4 kb upstream of the start site of transcription of the mouse 
TAT gene. This dexamethasone-dependent hypersensitive site suggested to us the 
possibility that glucocorticoid response elements might be located far upstream of the 
start site of transcription. 
To identify sequences important for the hormonal control of these two genes by 
glucocorticoids, fusion genes were constructed containing the 5' flanking DNA of 
these genes upstream of a suitable indicator gene. We used either the bacterial gene 
for neomycin resistance (neo) or the gene for the enzyme chloramphenicol trans-
acetylase (CAT). A typical hybrid gene is shown in FIGURE 3. Because chromatin 
studies have suggested that the control sequence might be remote from the cap-site22 (FIG. 2), 2.9 kb of 5' flanking DNA was included in the construction of this hybrid 
gene. In the case of the TO promoter, a CAT fusion gene containing 1.9 kb of 5' 
flanking DNA was constructed. These fusion genes were introduced into hepatoma 
cells and fibroblasts, and the effect of steroid administration on expression of these 
genes was analyzed by CAT enzyme activity measurements or analysis of the RNA 
with RNA filter hybridization experiments and /or with SI nuclease analysis. Both 
FIGURE 3 . Structure of pTATneo, a fusion gene of the 
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FIGURE 4 . Expression of TO-CAT recombinants in mouse L cells. TO-CAT recombinants 
containing approximately 1930 bp, 600 bp, and 340 bp of 5' flanking sequences were transferred 
into mouse L cells. Expression in the presence and absence of dexamethasone was followed by 
measuring CAT activity in extracts of the cells 48 hr after transfection. 
genes, when introduced into heterologous or homologous cells, are expressed, and the 
expression is regulated by glucocorticoids (data not shown). In order to delineate the 
important regulatory elements in more detail, deletion mutants of these parental 
plasmids were constructed and tested. A typical experiment is shown in FIGURE 4 
for the T O - C A T recombinants expressed in mouse L cells. It is seen that as long as 
1930 nucleotides remain of 5' flanking sequences of the T O fusion gene, strong in-
Xbal Oral 
A t» 
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TGTTCT 
rTGT* TCTTGT DEX INDUCTION 
OF CAT ACTIVITY 
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1.7x -
1.9 x N.D. 
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FIGURE 5. A remote DNA sequence confers glucocorticoid responsiveness and receptor bind-
ing. The upper part of the figure shows the 5' flanking part of the TAT gene fused onto the 
CAT gene. Deletion derivatives as indicated by the deletion end points were tested for dexa-
methasone inducibility of expression of the CAT recombinants in L cells 12 hr after hormone 
treatment as well as for receptor binding. The approximate position of the hexanucleotide 
(TGTTCT) indicative of glucocorticoid receptor binding sites is shown. 
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FIGURE 6. Binding of the glucocorticoid receptor to 5' deletions of the TAT-CAT recombinant. 
The upper part of the figure shows the method employed to determine binding of the purified 
glucocorticoid receptor to 5' deletion derivatives of the TAT-CAT plasmids. The lower part of 
the figure shows the results of a filter binding experiment with three plasmids containing 5' 
flanking TAT DNA as indicated in the presence of increasing amounts of competing calf thymus 
DNA (CT DNA). The inset shows the autoradiogram of the fragments preferentially retained 
on nitrocellulose filters. The top set of fragments represents the deletion ending at -2561; the 
middle set, the deletion ending at -1890; and the lower set, the deletion ending at -1300. For 
quantitation the bands were cut out and counted. The data are plotted as percentages of binding 
of the deletion ending at -2561. 
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auction of expression by glucocorticoids can be achieved. Deletion of 5' flanking 
sequences up to about - 5 0 0 resulted in considerable loss of inducibility, even though 
some induction of the TO-CAT recombinant can still be observed. Further deletion 
to -314 abolished all inducibility. These findings suggest the presence of two hormone-
responsive elements in the 5' flanking region of the TO gene. These results were further 
confirmed by more finely spaced deletion mutants. 
A similar series of experiments was conducted with the TAT fusion genes, which 
were introduced in rat hepatoma cells and mouse fibroblasts. In mouse L cells the 
TAT 5' flanking sequence of 2.95 kb conferred strong inducibility of expression. 
Expression studies of 5' deletion derivatives of the parental TAT-CAT recombinant 
G G T C A G A G C C T C i G G A G G A C C C C T G A A G I C T C T T C T C A GIT G T T C TIC T A T C 
C C A G T C T C G C- A G A C C T C C T G G G G A C T T C A G A G A A G A G T C A C .'. A G A G A T A G 
A C A G G A G A G C T G T C A G C C C C T G G A A [ G T G G T T C T A T G T C T A 6 A A A A C T A 
T G T C C C T C T C G A C A G T C G G G G A C C T T A C A C C A A G A T A C A G A T C T T T T G A I 
f 
T C C C A T A A A T A A C A G G A A G C C C A A G G T T T A C C A A I C T C T G C T G T A C A 6 6 A 
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_ ! . f . .4.. f f 
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C A C A C C A C C A T A T C G G G A C A T T A G G G T C G T A A A C C C T T C G A C T C C A C C C T 
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FIGURE 7. Sequence of the far 5' flanking DNA of the TAT gene. The DNA sequence between 
-2650 and -2200 of the TAT gene is presented. The three hexanucleotides TGTTCT characteristic 
of receptor binding sites are shown in boxes. The regions protected from DNase I digestion after 
binding of the glucocorticoid receptor in vitro are shown in boldface type. DNase I hypersensitive 
regions are shown with dots. Protected and enhanced guanine residues as evidenced from dimethyl 
sulfate protection experiments are shown with upward- and downward-pointing arrows, respec-
tively. The DNase I and dimethyl sulfate protection experiments have been performed with the 
upper strand only. 
defined important control elements in the region that showed a local alteration in 
chromatin structure in the previous DNase I hypersensitivity studies (FIG. 5). In-
spection of the DNA sequence within this region revealed sequences homologous to 
the glucocorticoid receptor binding sites of the mouse mammary tumor virus,23,24 
methallothionin,25 and lysozyme26,27 genes. 
To determine whether this control element located so far upstream of the initiation 
site of transcription functions as a glucocorticoid receptor binding site, filter binding 
studies with the purified glucocorticoid receptor and the 5' deletion mutants were 
performed. Binding of the glucocorticoid receptor to TAT 5' deletion derivatives was 
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the purified receptor interacts preferentially with the deletion mutant that contains 
the control sequence identified in vivo, but not with derivatives ending at -1890 or 
-1300. The DNA filter binding studies were complemented by DNase I footprint 
analyses as well as by dimethyl sulfate protection experiments (data not shown). Two 
footprinting regions could be identified in the far upstream sequence of the TAT gene 
using a purified glucocorticoid receptor. These protected regions are indicated by the 
shaded sequence in FIGURE 7. Dimethyl sulfate protection experiments indicate contact 
sites of the receptor. Protections and enhancements indicated by the arrows in FIGURE 
7 are seen in the sequences defined by the DNase I footprints. These nuclease protection 
experiments identify partially homologous receptor binding sites located in the region 
that confer glucocorticoid responsiveness in vivo. 
CONCLUSIONS 
Induction of enzyme activity for TO and TAT, two gluconeogenic enzymes, results 
from increased expression of the respective genes at the transcriptional level. The 
effect of the hormone on transcription is rapid and does not require new protein 
synthesis, suggesting a direct effect of the hormone receptor complex on the activity 
of the gene. In order to identify sequences important for regulation, fusion genes 
containing the presumptive control sequences were constructed and their expression 
studied under the influence of steroid hormones. This has allowed identification of 
two control sequences in the case of the TO gene located around -420 and around 
-1190 and control elements located at about -2500 bp upstream of the TAT initiation 
site. The responsible sequences show strong sequence homology to each other as well 
as to previously characterized glucocorticoid control elements.23-27 What role these 
hormonal control elements play in the course of developmental activation of these 
genes will now be tested by analysis of expression of these genes in transgenic animals. 
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